CYP4B1 and urothelial carcinoma: Moreover, downregulation of CYP4B1 protein levels in urothelial carcinomas (UC) was found to be correlated with several clinicopathological factors of an advanced primary tumor, nodal metastasis, high histological grade, vascular invasion, perineural invasion, and mitotic rate.